Some patients reluctantly shifted to save money while others have appealed for coverage of Zepbound after having experienced ...

These healthcare leaders still could perform well in the long run. Novo Nordisk has been facing several challenges that ...

Tack on a half-dozen zeros to your CVS receipt and you'll get a sense of the sticker shock afflicting state officials, insurers and hospitals dealing with the soaring cost of prescription drugs in ...

"My scene was supposed to be funny, and it got nothing in the f---ing Chinese Theatre," the comedian says while discussing ...

Scientists have revealed a potential 'neurobiotic' sixth sense derived from direct communication between microorganisms and ...

In a study on people with obesity and asthma, researchers saw “significant” improvements in the asthma scores of people who had been on GLP-1 medications for a year.

Researchers in a recent study discovered that people taking medications to help them lose weight might experience weight gain ...

Editors: Story has been updated from original, with material from the president of the Arizona Obesity Organization. Slug: ...

GoodRx reports that insurance coverage for GLP-1 medications varies. It's more likely when prescribed for FDA-approved uses ...

A spokesperson said: “Results from the STEP trials demonstrate that weight regain is likely once medication is stopped.

Ozempic and Mounjaro are both very popular for weight loss at the minute, but there's one big difference between the two ...

Hims & Hers (NYSE:HIMS) stock slips as U.S. lawmakers seek FDA action against copycat versions of weight loss drugs from Novo ...